How to Apply for a Certificate of Product Registration (CPR)
The Certificate of Product Registration (CPR) is a mandatory document issued by the Philippine Food and Drug Administration (FDA) that certifies a health product has been evaluated and found to be safe, effective, and of good quality. Before any FDA-regulated product can be legally marketed, distributed, or sold in the Philippines, it must first obtain a CPR. This guide will walk you through the entire CPR application process, from determining your product classification to receiving your certificate.
What is a Certificate of Product Registration (CPR)?
A CPR is an official document issued by FDA Philippines that certifies a product's safety, efficacy, and quality for human use or consumption. It serves as proof that the product has undergone thorough technical evaluation and meets Philippine regulatory standards.
- Validity: A CPR is valid for 5 years from the date of issuance and must be renewed before expiration
- Prerequisite: You must first obtain a valid License to Operate (LTO) for your establishment BEFORE you can apply for a CPR
- Legal Basis: Republic Act No. 9711 (FDA Act of 2009) requires all health products to be registered with FDA before they can be marketed in the Philippines
- Scope: CPR is required for drugs/medicines, medical devices (Class B-D), high-risk processed food, food supplements, household hazardous substances, and other regulated products
- Registry Number: Upon approval, the product is assigned a unique FDA registration number (e.g., FR-XXXXXXX for food, DR-XXXXXXX for drugs) that must be displayed on the product label
⚠ Important: CPR vs. Product Notification
Not all FDA-regulated products require a full CPR. Some low-risk products only require a product notification. It is critical to determine the correct pathway for your product:
Products Requiring CPR (Full Registration):
- All drugs and medicines (prescription and OTC)
- Medical devices (Class B, C, and D)
- High-risk processed food products
- Food supplements with health claims
- Household hazardous substances
- Veterinary products
Products Requiring Notification Only:
- Cosmetics (most categories)
- Low-risk processed food products
- Medical devices (Class A only)
- Toys and childcare articles
⚠ Selling unregistered or unnotified health products in the Philippines is a criminal offense under RA 9711, punishable by imprisonment and/or fines of up to ₱5,000,000.
CPR vs. Product Notification: Comparison
Understanding the difference between CPR and product notification is essential to determine the correct application pathway for your product. Below is a detailed comparison:
| Criteria | Certificate of Product Registration (CPR) | Product Notification |
|---|---|---|
| When Required | For high-risk and medium-risk health products that require thorough technical evaluation before market entry | For low-risk products where a simplified notification process is sufficient |
| Risk Level | Medium to High Risk (drugs, Class B-D devices, high-risk food, hazardous substances) | Low Risk (cosmetics, low-risk food, Class A devices) |
| Processing Time | 30 to 120 working days depending on product category and completeness of documents | 7 to 20 working days for complete applications |
| Documents Required | Full product dossier, lab analysis, stability data, GMP certificate, clinical data (for drugs), risk classification (for devices) | Product information form, label samples, list of ingredients, proof of product safety |
| Fees | ₱3,000 to ₱50,000+ depending on product category and type of application | ₱1,000 to ₱5,000 depending on product category |
| Validity | 5 years from date of issuance | 5 years from date of issuance (for most categories) |
| Evaluation Process | Full technical review, possible laboratory testing, GMP inspection, expert panel evaluation (for drugs) | Document review and verification; no extensive technical evaluation |
Products Requiring a CPR
The following product categories must obtain a Certificate of Product Registration before they can be legally sold, distributed, or marketed in the Philippines:
| Product Category | Examples | Risk Level | Key Requirements |
|---|---|---|---|
| Drugs & Medicines | Prescription drugs, OTC medicines, generic drugs, traditional herbal medicines | High | Full dossier (CTD format), bioequivalence studies, stability data, GMP certificate |
| Medical Devices (Class B-D) | Surgical instruments, diagnostic kits, implants, patient monitors, imaging equipment | Medium to High | Technical documentation, risk classification, clinical evidence, ISO 13485 compliance |
| Processed Food (High Risk) | Infant formula, special dietary food, food for special medical purposes | High | Laboratory analysis, nutrition facts panel, label compliance, HACCP plan |
| Food Supplements | Vitamins, minerals, amino acids, herbal supplements, probiotics with health claims | Medium | Product formula, certificate of analysis, stability data, label with supplement facts |
| Household Hazardous Substances | Insecticides, disinfectants, cleaning agents with hazardous chemicals, pesticides | High | Safety data sheet, toxicity data, product formula, hazard classification, first aid information |
Note: FDA may reclassify products or update registration requirements through Administrative Orders and Circulars. Always verify the latest classification with FDA before submitting your application.
Step-by-Step CPR Application Process
Follow these steps carefully to apply for a Certificate of Product Registration with the Philippine FDA. Ensure all requirements are complete before submitting your application to avoid delays.
Verify You Have a Valid LTO
Before applying for a CPR, you must have a valid and current License to Operate (LTO) issued by FDA for your establishment. The LTO must cover the type of activity (manufacturing, importing, distributing, etc.) relevant to the product you intend to register.
💡 Tip: If you do not yet have an LTO, you must apply for one first. The LTO application process typically takes 20-30 working days. Visit our LTO Application guide for detailed instructions.
- Check your LTO expiration date — it must remain valid throughout the CPR application process
- Ensure your LTO covers the correct product category and activity type
- For imported products, both the importer's and the manufacturer's relevant licenses must be in order
- Your LTO number will be required when filing the CPR application
Determine Product Classification
Identify which FDA product category your product falls under. The classification determines the specific requirements, documentary submissions, fees, and evaluation process for your CPR application.
| Category | Registration Pathway | Regulatory Reference |
|---|---|---|
| Drugs & Medicines | CPR (Full Registration via CTD) | AO 2020-0017, AO 2016-0003 |
| Medical Devices | CPR (Risk-based: Class B, C, D) | AO 2018-0002, FDA Circular 2019-004 |
| Processed Food | CPR (high-risk) or Notification (low-risk) | AO 2014-0029, FDA Circular 2016-014 |
| Food Supplements | CPR (with health claims) or Notification | AO 2014-0029, AO 2016-0014 |
| Household Hazardous Substances | CPR (all products) | AO 2020-0030, RA 9711 IRR |
If you are unsure about your product's classification, you may submit a formal query to the FDA Product Classification Committee or visit the FDA Center for Product Standards and Quality (CPSQ).
Prepare Product Dossier/Documentation
Compile all required documentation for your product application. The specific documents depend on your product category. Incomplete submissions are the most common cause of application delays.
For Drugs & Medicines:
- Common Technical Document (CTD) — Module 1 (Administrative), Module 2 (Summaries), Module 3 (Quality), Module 4 (Non-clinical), Module 5 (Clinical)
- Certificate of Analysis (COA) for active ingredients and finished product
- Bioequivalence study (for generic drugs)
- Stability data (accelerated and long-term studies)
- GMP Certificate of Compliance or WHO prequalification
- Certificate of Product Registration from country of origin (for imported drugs)
- Proposed product labels and package inserts in English and Filipino
For Processed Food & Food Supplements:
- Product information form with complete list of ingredients
- Laboratory analysis results (microbiological, chemical, physical tests)
- Nutrition facts panel compliant with FDA labeling guidelines
- Product label artwork (front, back, and side panels)
- HACCP plan or food safety management system documentation
- Shelf-life study data or stability testing results
- Certificate of Free Sale from country of origin (for imported products)
For Medical Devices (Class B-D):
- Technical documentation file (device description, specifications, intended use)
- Risk classification documentation per ASEAN Medical Device Directive
- Declaration of Conformity and applicable test reports
- Clinical evidence (clinical evaluation report or clinical investigation data)
- ISO 13485 certificate (Quality Management System for medical devices)
- Instructions for use (IFU) and product labeling
- Post-market surveillance plan
For Household Hazardous Substances:
- Safety Data Sheet (SDS) in accordance with the Globally Harmonized System (GHS)
- Toxicological data and acute toxicity test results
- Complete product formula with concentration of active and hazardous ingredients
- Hazard classification and precautionary statements
- First aid information and emergency procedures
- Product label with proper hazard pictograms and signal words
Submit Application via FDA eServices
All CPR applications must be submitted online through the FDA eServices Portal. Paper-based applications are no longer accepted for product registration.
- Log in to the FDA eServices Portal using your registered account credentials
- Navigate to "Product Registration" and select the appropriate product category
- Fill out the online application form with accurate product details (product name, dosage form, strength, formulation, etc.)
- Upload all required documents in PDF format (file size limits apply — check the portal for current maximum file sizes)
- Review your application thoroughly before final submission — you cannot easily modify submitted applications
- Submit the application and note your reference/tracking number for monitoring
💡 Tip: Ensure your internet connection is stable during upload. Large dossier files (especially for drug applications) may take time to upload. It is recommended to compress documents and use bookmarked PDF files for the CTD modules.
Pay Processing Fees
After successful submission, a Payment Assessment Notice (PAN) will be generated by the system. You must pay the required processing fees within the prescribed period to avoid cancellation of your application.
- Download the Payment Assessment Notice from the FDA eServices portal
- Pay through any of the FDA-accredited payment channels: Landbank, Philippine Veterans Bank, GCash, or over-the-counter at the FDA Cashier
- Retain the official receipt as proof of payment — you will need to upload it to the portal
- Upload the scanned proof of payment to the FDA eServices portal within the specified deadline
- Payment must be made within 15 calendar days from issuance of the PAN; otherwise, the application may be cancelled
FDA Technical Evaluation / Laboratory Testing
Once payment is confirmed, your application enters the technical evaluation phase. FDA evaluators will review your product dossier, and in some cases, laboratory testing may be required.
Document Screening
FDA staff will check if all required documents are submitted and properly formatted. If documents are incomplete or deficient, a Deficiency Notice will be issued, and you will be given a deadline (usually 30 days) to submit the missing requirements.
Technical Evaluation
FDA evaluators conduct a thorough review of the product's safety, efficacy, and quality data. For drugs, this includes review of clinical, non-clinical, and quality data in the CTD. For food, this includes review of lab results and labeling compliance.
Laboratory Testing (if required)
FDA may require product samples for independent laboratory testing at the FDA Laboratory Services Division. This typically applies to drugs, food products, and hazardous substances. You will be notified if product samples need to be submitted.
Expert Panel Review (for drugs)
New chemical entities and certain drug products may be referred to the FDA Advisory Committee or Expert Panel for additional evaluation. This may extend the processing timeline but ensures thorough assessment of product safety and efficacy.
⚠ Note: Respond promptly to any Deficiency Notices issued by FDA. Failure to respond within the given deadline may result in automatic cancellation of your application and forfeiture of fees paid.
Issuance of CPR
Upon successful completion of the technical evaluation and if the product meets all FDA requirements, the Certificate of Product Registration will be issued.
- The CPR will be issued electronically and can be downloaded from the FDA eServices portal
- Your product will be assigned a unique FDA registration number that must be printed on the product label
- The CPR is valid for 5 years from the date of issuance
- You may now legally manufacture, import, distribute, and sell the registered product in the Philippines
- The product will appear in the FDA Product Registry, which is searchable by the public through the FDA Verification Portal
💡 Remember: Start your CPR renewal application at least 6 months before expiration to ensure continuity of your product registration. An expired CPR means you must stop selling the product until renewal is approved.
Requirements by Product Category
The table below summarizes the key documentary requirements for CPR applications across different product categories:
| Requirement | Drugs | Food | Cosmetics | Medical Devices |
|---|---|---|---|---|
| Product Dossier/Technical File | Full CTD (5 modules) | Product information form | Safety assessment report | Technical documentation file |
| Laboratory Analysis | COA, dissolution, assay | Micro, chemical, physical | Micro, heavy metals, stability | Performance testing, biocompatibility |
| Stability Data | Accelerated + long-term | Shelf-life study | Stability testing | Shelf-life/expiry validation |
| Clinical/Safety Data | Bioequivalence studies, clinical trials | Nutrition facts panel | Product formula, safety assessment | Clinical evaluation report |
| Manufacturing Compliance | GMP Certificate (PIC/S or WHO) | HACCP / GMP | GMP / ASEAN GMP | ISO 13485 / QMS |
| Label/Packaging | Label, package insert, carton | Label with nutrition facts | Label with ingredient list | IFU, label, packaging |
| Import Documents (if applicable) | CPR from origin, GMP of manufacturer | Certificate of Free Sale | Certificate of Free Sale | Free Sale Certificate, CE mark (if EU) |
CPR Application Fees
The following are the standard processing fees for CPR applications. Actual fees may vary based on FDA administrative orders and product-specific requirements. Always confirm the latest fee schedule on the FDA website or eServices portal.
| Product Category | New Registration | Renewal | Variation/Amendment |
|---|---|---|---|
| Drugs — New Chemical Entity | ₱30,000 - ₱50,000 | ₱15,000 - ₱25,000 | ₱5,000 - ₱15,000 |
| Drugs — Generic | ₱15,000 - ₱30,000 | ₱8,000 - ₱15,000 | ₱3,000 - ₱10,000 |
| Medical Devices (Class B) | ₱5,000 - ₱10,000 | ₱3,000 - ₱5,000 | ₱2,000 - ₱5,000 |
| Medical Devices (Class C-D) | ₱10,000 - ₱25,000 | ₱5,000 - ₱15,000 | ₱3,000 - ₱10,000 |
| Processed Food (High Risk) | ₱3,000 - ₱10,000 | ₱2,000 - ₱5,000 | ₱1,500 - ₱5,000 |
| Food Supplements | ₱5,000 - ₱15,000 | ₱3,000 - ₱8,000 | ₱2,000 - ₱5,000 |
| Household Hazardous Substances | ₱5,000 - ₱15,000 | ₱3,000 - ₱8,000 | ₱2,000 - ₱5,000 |
Note: Fees shown are approximate ranges based on current FDA fee schedules. Additional fees may apply for laboratory testing, expedited processing, or supplemental submissions. Contact FDA or check FDA Administrative Order No. 2020-0024 for the complete fee schedule.
Complete Example: ABC Pharma Registers a New Generic Medicine
Let's walk through a realistic example of a pharmaceutical company applying for a CPR for a new generic drug product. This example illustrates the complete process from preparation to issuance.
Scenario: ABC Pharma Inc. — Generic Amoxicillin 500mg Capsules
Background:
ABC Pharma Inc. is a Philippine-based pharmaceutical manufacturer with a valid FDA LTO (LTO No. FDA-LTO-XXXX-1234). They want to register a new generic Amoxicillin 500mg Capsule for the Philippine market. Amoxicillin is a well-established antibiotic and a generic version requires a CPR with bioequivalence data.
Step 1: Verify LTO Status
ABC Pharma confirms their LTO is valid until 2028 and covers drug manufacturing activities. Their GMP Certificate of Compliance (issued by FDA after GMP inspection) is also current. They are cleared to proceed with the CPR application.
Step 2: Product Classification
Amoxicillin 500mg Capsule is classified as a generic drug product. The registration pathway is CPR via the Common Technical Document (CTD) format. As a generic drug, a bioequivalence study referencing the innovator product is required.
Step 3: Prepare Product Dossier
ABC Pharma compiles the following CTD modules:
- Module 1: Administrative information, application form, LTO copy, GMP certificate, proposed label and package insert
- Module 2: Quality Overall Summary (QOS), Non-clinical Overview, Clinical Overview
- Module 3: Drug substance specifications (API from certified supplier), drug product formulation, manufacturing process, validation data, stability data (6 months accelerated + 12 months long-term)
- Module 4: Not required for generic drugs (reference to innovator's non-clinical data)
- Module 5: Bioequivalence study report (conducted at an FDA-recognized BE center, showing pharmacokinetic equivalence to the innovator product)
Step 4: Submit via FDA eServices
ABC Pharma's Regulatory Affairs team logs into the FDA eServices Portal. They select "Drug Product Registration — Generic" and fill out the application form with product details: Amoxicillin Trihydrate 500mg Capsule, hard gelatin capsule, box of 100 capsules. They upload the complete CTD in PDF format (bookmarked and hyperlinked). Application reference number: PR-2024-XXXXX.
Step 5: Pay Processing Fees
FDA generates a Payment Assessment Notice for ₱20,000 (generic drug new registration). ABC Pharma pays through Landbank within 10 days and uploads the official receipt to the portal.
Step 6: FDA Technical Evaluation
The application undergoes the following evaluation stages:
- Week 1-2: Document screening — complete, no deficiencies noted
- Week 3-8: Technical evaluation of Module 3 (quality data) — reviewer requests additional dissolution data; ABC Pharma responds within 15 days
- Week 9-10: Bioequivalence data review (Module 5) — reviewer confirms BE study meets FDA criteria
- Week 11-12: Label and packaging review — minor correction requested on package insert (dosage instructions); ABC Pharma submits revised label
- Week 13-14: Final review and recommendation for approval
Step 7: CPR Issuance
After 14 weeks (approximately 70 working days), the CPR is approved and issued. ABC Pharma receives:
- CPR with registration number DR-XXXXXXX, valid for 5 years
- Approved product label and package insert
- Permission to manufacture and distribute Amoxicillin 500mg Capsules in the Philippine market
Total Timeline: Approximately 14-16 weeks
Total Cost: ₱20,000 (registration fee) + ₱150,000-300,000 (bioequivalence study) + ₱50,000-100,000 (stability studies and lab testing) = approximately ₱220,000 - ₱420,000 total investment per product
Frequently Asked Questions (FAQ)
Q1: How long does it take to get a CPR?
Processing times vary by product category. For drugs and medicines, expect 60-120 working days. For processed food and food supplements, processing typically takes 30-60 working days. Medical devices may take 45-90 working days depending on risk classification. These timelines assume complete and deficiency-free submissions. Incomplete applications or deficiency notices can significantly extend the timeline.
Q2: How do I register an imported product?
For imported products, the Philippine importer (who must hold a valid FDA LTO as an importer) files the CPR application. In addition to the standard requirements, you must submit: (a) Certificate of Product Registration or Certificate of Free Sale from the country of origin, (b) GMP Certificate of the foreign manufacturer, (c) Authorization letter from the foreign manufacturer appointing the Philippine importer as their authorized representative, and (d) Proof of product registration in at least one reference country (for drugs). All foreign documents must be authenticated or apostilled.
Q3: What are the labeling requirements for registered products?
All FDA-registered products must display the following on their labels: (a) Product name and generic/common name, (b) FDA registration number (e.g., FR-XXXXXXX, DR-XXXXXXX), (c) Name and address of the manufacturer and/or importer, (d) Net content and batch/lot number, (e) Manufacturing and expiry dates, (f) List of ingredients in descending order, (g) Storage conditions and warnings, (h) Directions for use. Labels must be in English and/or Filipino. Drug products require a detailed package insert. Food products require a nutrition facts panel. Non-compliance with labeling requirements is grounds for CPR cancellation.
Q4: Can I modify a registered product after getting the CPR?
Yes, but any changes to a registered product require a formal Variation Application filed through the FDA eServices Portal. Variations are classified as: (a) Minor Variation — changes that do not affect product safety, quality, or efficacy (e.g., label redesign, change of packaging material). These are processed within 15-30 working days. (b) Major Variation — changes that may affect product safety, quality, or efficacy (e.g., change in formulation, change of manufacturer, addition of new indication). These require full technical evaluation and may take 45-90 working days. Selling a product with unauthorized variations is a violation of FDA regulations.
Q5: Can I register multiple SKUs under one CPR?
Generally, each distinct product formulation requires its own CPR. However, different pack sizes or packaging presentations of the same product (same formulation, same manufacturer, same dosage form/strength) may be included under a single CPR application as line extensions. For example, Amoxicillin 500mg Capsules in a box of 10, box of 30, and box of 100 may be registered under one CPR. However, Amoxicillin 500mg Capsules and Amoxicillin 250mg Capsules are different products and require separate CPR applications.
Q6: What happens if my CPR application is denied?
If your CPR application is denied, FDA will issue a formal Notice of Denial stating the specific grounds for rejection. Common reasons include: incomplete documentation, failed laboratory tests, non-compliance with GMP, inadequate safety/efficacy data, or labeling deficiencies. You may: (a) Address the deficiencies and re-apply as a new application (with new fees), (b) File a Motion for Reconsideration within 15 days from receipt of the denial if you believe the decision is incorrect or you have additional supporting data, or (c) Appeal to the Department of Health (DOH) Secretary within 30 days if the reconsideration is also denied. Fees paid for denied applications are non-refundable.
Important Reminders
- LTO First: You cannot apply for a CPR without a valid License to Operate (LTO). The LTO must be current and must cover the correct product category and establishment type
- Complete Submissions: Ensure all required documents are complete and properly formatted before submission. Incomplete applications are the number one cause of delays — FDA will issue a Deficiency Notice and your application will be on hold until resolved
- Monitor Your Application: Regularly check the status of your application on the FDA eServices Portal. Respond to any Deficiency Notices within the given deadline (usually 30 days) to prevent automatic cancellation
- Label Compliance: All product labels must comply with FDA labeling requirements BEFORE the product enters the market. Non-compliant labels are a common reason for CPR delays and post-market enforcement actions
- GMP Compliance: Your manufacturing facility must maintain GMP compliance throughout the validity of the CPR. FDA may conduct unannounced GMP inspections, and non-compliance can result in CPR suspension or cancellation
- Renewal: Start the CPR renewal process at least 6 months before expiration. Operating with an expired CPR is equivalent to selling an unregistered product, which is a criminal offense
- Post-Market Obligations: After receiving your CPR, you are required to report adverse events, maintain product quality, comply with FDA recall orders, and submit periodic safety update reports (for drugs)
- Keep Records: Maintain complete records of all product registration documents, correspondence with FDA, laboratory test results, and distribution records for at least 5 years after the CPR expires
- Authorized Personnel: Only authorized representatives (registered pharmacists for drugs, qualified technical persons for other categories) should sign and submit CPR applications
- No Unauthorized Changes: Do not modify the product formulation, labeling, packaging, or manufacturing site without first obtaining FDA approval through a formal Variation Application
Need Help?
If you have questions about the CPR application process or need assistance, you can reach the FDA through the following channels:
- FDA Hotline: (02) 8857-1900 (available Monday to Friday, 8:00 AM to 5:00 PM)
- Email: info@fda.gov.ph
- FDA Website: www.fda.gov.ph
- FDA eServices Portal: eservices.fda.gov.ph
- FDA Main Office: Civic Drive, Filinvest Corporate City, Alabang, Muntinlupa City, 1781
- Center for Drug Regulation and Research (CDRR): For drug product registration inquiries
- Center for Food Regulation and Research (CFRR): For food and food supplement registration inquiries
- Center for Device Regulation, Radiation Health, and Research (CDRRHR): For medical device registration inquiries
💡 Tip: For complex product registration queries, you may request a pre-submission meeting with the relevant FDA Center. This can help clarify requirements, identify potential issues early, and expedite your application process.
Disclaimer
This guide is provided for general informational purposes only. The requirements, steps, fees, and procedures mentioned here may vary depending on the FDA you visit. We recommend visiting your nearest FDA first to confirm the specific requirements and process before preparing your documents.